Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Free Report) have earned an average rating of “Moderate Buy” from the eight ratings firms that are presently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $18.86.
SBRA has been the subject of several recent analyst reports. JMP Securities upgraded shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 target price for the company in a research report on Tuesday, January 7th. Mizuho reiterated a “neutral” rating and set a $20.00 price objective on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Truist Financial cut Sabra Health Care REIT from a “buy” rating to a “hold” rating and lowered their target price for the company from $18.00 to $17.00 in a research report on Friday, January 17th. Finally, Citizens Jmp raised Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th.
Get Our Latest Stock Analysis on SBRA
Hedge Funds Weigh In On Sabra Health Care REIT
Sabra Health Care REIT Trading Down 0.2 %
Sabra Health Care REIT stock opened at $16.39 on Thursday. Sabra Health Care REIT has a 1 year low of $13.31 and a 1 year high of $20.03. The firm’s 50-day moving average is $16.78 and its 200-day moving average is $17.62. The company has a debt-to-equity ratio of 0.88, a quick ratio of 4.16 and a current ratio of 4.32. The company has a market cap of $3.90 billion, a P/E ratio of 30.93, a PEG ratio of 1.97 and a beta of 1.25.
Sabra Health Care REIT (NASDAQ:SBRA – Get Free Report) last released its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share for the quarter, hitting the consensus estimate of $0.36. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The firm had revenue of $182.35 million for the quarter, compared to analyst estimates of $178.01 million. On average, equities analysts expect that Sabra Health Care REIT will post 1.45 earnings per share for the current year.
Sabra Health Care REIT Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Friday, February 14th will be given a $0.30 dividend. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 7.32%. Sabra Health Care REIT’s dividend payout ratio (DPR) is 226.42%.
About Sabra Health Care REIT
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Featured Articles
- Five stocks we like better than Sabra Health Care REIT
- 3 Best Fintech Stocks for a Portfolio Boost
- Buffett’s on the Sidelines – Should You Follow?
- What Are Growth Stocks and Investing in Them
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- How to Plot Fibonacci Price Inflection Levels
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.